Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Libert

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Acta Tuberculosea Et Pneumologica Belgica|September 1, 1974
[Prophylactic administration of Bactrim in chronic bronchitis. A double blind clinical and biological study (author's transl)]M Bruninx, J P De Koster, P Golard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancerJ Klastersky, J P Sculier, F Ries, et al.
Revue Des Maladies Respiratoires|January 1, 1994
[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party]J P Sculier, M Paesmans, G Bureau, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working PartyJ J Body, J C Dumon, J P Sculier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working PartyJ Klastersky, J P Sculier, F Ries, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Reliability of a new device to assess the oxygen consumption of human respiratory musclesS Ahmaidi, D Comte, N Topin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Acta Tuberculosea Et Pneumologica Belgica|September 1, 1974
[Prophylactic administration of Bactrim in chronic bronchitis. A double blind clinical and biological study (author's transl)]M Bruninx, J P De Koster, P Golard, et al.
Lung Cancer (Amsterdam, Netherlands)|December 1, 1994
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancerJ Klastersky, J P Sculier, F Ries, et al.
Revue Des Maladies Respiratoires|January 1, 1994
[Small cell bronchial cancer. Comparison of results of weekly polychemotherapy using multiple drugs with standard chemotherapy. European Lung Cancer Working Party]J P Sculier, M Paesmans, G Bureau, et al.
Henry Ford Hospital Medical Journal|January 1, 1989
A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working PartyJ J Body, J C Dumon, J P Sculier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working PartyJ P Sculier, M Paesmans, G Bureau, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil. A regimen associated with major toxicity in patients with advanced non-small lung cancer. European Lung Cancer Working PartyJ Klastersky, J P Sculier, F Ries, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Reliability of a new device to assess the oxygen consumption of human respiratory musclesS Ahmaidi, D Comte, N Topin, et al.
European Journal of Cancer (Oxford, England : 1990)|June 9, 1998
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working PartyM Paesmans, J P Sculier, P Libert, et al.
Cancer|August 10, 2000
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 yearsM Paesmans, J P Sculier, J Lecomte, et al.
Revue Des Maladies Respiratoires|March 13, 1998
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party]J P Sculier, M Paesmans, P Libert, et al.
Pageof 12